Literature DB >> 19439544

Genotypic prediction of human immunodeficiency virus type 1 CRF02-AG tropism.

Stéphanie Raymond1, Pierre Delobel, Maud Mavigner, Michelle Cazabat, Corinne Souyris, Stéphanie Encinas, Karine Sandres-Sauné, Christophe Pasquier, Bruno Marchou, Patrice Massip, Jacques Izopet.   

Abstract

We assessed the performance of genotypic algorithms for predicting the tropism of human immunodeficiency virus type 1 coreceptor usage in 52 patients infected with the CRF02-AG subtype. The combined criteria of the 11/25 and net charge rules accurately detected CXCR4-using CRF02-AG viruses, whereas the Geno2pheno tool lacked sensitivity and the position-specific scoring matrix (PSSM) tool WebPSSM lacked specificity.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19439544      PMCID： PMC2708518          DOI： 10.1128/JCM.02439-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages).

Authors:  D R Briggs; D L Tuttle; J W Sleasman; M M Goodenow
Journal:  AIDS       Date:  2000-12-22       Impact factor: 4.177

2.  Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage.

Authors:  Laurence Vergne; Anke Bourgeois; Eitel Mpoudi-Ngole; Rose Mougnutou; Josephine Mbuagbaw; Florian Liegeois; Christian Laurent; Christelle Butel; Léopold Zekeng; Eric Delaporte; Martine Peeters
Journal:  Virology       Date:  2003-06-05       Impact factor: 3.616

3.  A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.

Authors:  Mark A Jensen; Mia Coetzer; Angélique B van 't Wout; Lynn Morris; James I Mullins
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  The challenge of HIV-1 subtype diversity.

Authors:  Barbara S Taylor; Scott M Hammer
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

5.  Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon.

Authors:  Denis M Tebit; Léopold Zekeng; Lazare Kaptué; Mika Salminen; Hans-Georg Kräusslich; Ottmar Herchenröder
Journal:  AIDS Res Hum Retroviruses       Date:  2002-01-01       Impact factor: 2.205

6.  Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.

Authors:  Joris Hemelaar; Eleanor Gouws; Peter D Ghys; Saladin Osmanov
Journal:  AIDS       Date:  2006-10-24       Impact factor: 4.177

7.  Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies.

Authors:  Pierre Delobel; Marie-Thérèse Nugeyre; Michelle Cazabat; Christophe Pasquier; Bruno Marchou; Patrice Massip; Françoise Barre-Sinoussi; Nicole Israël; Jacques Izopet
Journal:  J Clin Microbiol       Date:  2007-02-28       Impact factor: 5.948

8.  Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.

Authors:  Carolina Garrido; Vanessa Roulet; Natalia Chueca; Eva Poveda; Antonio Aguilera; Katharina Skrabal; Natalia Zahonero; Silvia Carlos; Federico García; Jean Louis Faudon; Vincent Soriano; Carmen de Mendoza
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

9.  Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.

Authors:  Stéphanie Raymond; Pierre Delobel; Maud Mavigner; Michelle Cazabat; Corinne Souyris; Karine Sandres-Sauné; Lise Cuzin; Bruno Marchou; Patrice Massip; Jacques Izopet
Journal:  AIDS       Date:  2008-09-12       Impact factor: 4.177

10.  Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.

Authors:  Mark A Jensen; Fu-Sheng Li; Angélique B van 't Wout; David C Nickle; Daniel Shriner; Hong-Xia He; Sherry McLaughlin; Raj Shankarappa; Joseph B Margolick; James I Mullins
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103
View more
  21 in total

1.  Low frequency of CXCR4-using viruses in patients at the time of primary non-subtype-B HIV-1 infection.

Authors:  Pierre Frange; Marie-Laure Chaix; Stéphanie Raymond; Julie Galimand; Christiane Deveau; Laurence Meyer; Cécile Goujard; Christine Rouzioux; Jacques Izopet
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

2.  Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study.

Authors:  Patricia Recordon-Pinson; Cathia Soulié; Philippe Flandre; Diane Descamps; Mouna Lazrek; Charlotte Charpentier; Brigitte Montes; Mary-Anne Trabaud; Jacqueline Cottalorda; Véronique Schneider; Laurence Morand-Joubert; Catherine Tamalet; Delphine Desbois; Muriel Macé; Virginie Ferré; Astrid Vabret; Annick Ruffault; Coralie Pallier; Stéphanie Raymond; Jacques Izopet; Jacques Reynes; Anne-Geneviève Marcelin; Bernard Masquelier
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

3.  Algorithm-based prediction of HIV-1 subtype D coreceptor use.

Authors:  Julia Dina; Stephanie Raymond; Anne Maillard; Helene Le Guillou-Guillemette; Audrey Rodalec; Agnes Beby-Defaux; Genevieve Giraudeau; Sophie Vallet; Thomas Mourez; Christopher Payan; Astrid Vabret; Annick Ruffault; Virginie Ferre; Jacques Izopet; Jean-Christophe Plantier
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

4.  HIV gp120 sequence variability associated with HAND in Hispanic Women.

Authors:  Krystal Colón; Fabián Vázquez-Santiago; Vanessa Rivera-Amill; Gisela Delgado; Steven E Massey; Valerie Wojna; Richard J Noel; Loyda M Meléndez
Journal:  J Virol Antivir Res       Date:  2015-10-06

5.  Impact of baseline HIV-1 tropism on viral response and CD4 cell count gains in HIV-infected patients receiving first-line antiretroviral therapy.

Authors:  Eduardo Seclén; Vicente Soriano; María M González; Luz Martín-Carbonero; Holger Gellermann; Manuel Distel; Werner Kadus; Eva Poveda
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

6.  Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response.

Authors:  Cathia Soulie; Gilles Peytavin; Charlotte Charpentier; Sidonie Lambert-Niclot; Sophie Sayon; Benoit Visseaux; Anne Simon; Christine Katlama; Yazdan Yazdanpanah; Diane Descamps; Vincent Calvez; Anne-Geneviève Marcelin
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12-17       Impact factor: 2.205

7.  Genotypic prediction of HIV-1 CRF01-AE tropism.

Authors:  Stéphanie Raymond; Pierre Delobel; Sylvie Rogez; Stéphanie Encinas; Patrick Bruel; Christophe Pasquier; Karine Sandres-Sauné; Bruno Marchou; Patrice Massip; Jacques Izopet
Journal:  J Clin Microbiol       Date:  2012-12-05       Impact factor: 5.948

8.  Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa.

Authors:  Joakim Esbjörnsson; Fredrik Månsson; Wilma Martínez-Arias; Elzbieta Vincic; Antonio J Biague; Zacarias J da Silva; Eva Maria Fenyö; Hans Norrgren; Patrik Medstrand
Journal:  Retrovirology       Date:  2010-03-22       Impact factor: 4.602

9.  Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping.

Authors:  Mattia C F Prosperi; Laura Bracciale; Massimiliano Fabbiani; Simona Di Giambenedetto; Francesca Razzolini; Genny Meini; Manuela Colafigli; Angela Marzocchetti; Roberto Cauda; Maurizio Zazzi; Andrea De Luca
Journal:  Retrovirology       Date:  2010-06-30       Impact factor: 4.602

10.  Comparison of genotypic and phenotypic HIV type 1 tropism assay: results from the screening samples of Cenicriviroc Study 202, a randomized phase II trial in treatment-naive subjects.

Authors:  Ron M Kagan; Erik P Johnson; Martin F Siaw; Ben Van Baelen; Richard Ogden; Jamie L Platt; Rick L Pesano; Eric Lefebvre
Journal:  AIDS Res Hum Retroviruses       Date:  2013-08-14       Impact factor: 2.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.